金橙子: 国投证券股份有限公司关于北京金橙子科技股份有限公司使用部分超募资金永久补充流动资金的核查意见

Core Viewpoint - The company intends to use part of the excess raised funds to permanently supplement its working capital, which is expected to enhance operational efficiency and reduce financial costs while aligning with the interests of all shareholders [1][4][5]. Fundraising Overview - The company was approved to publicly issue 25,666,700 shares at a price of RMB 80.88 per share, resulting in a total fundraising amount of approximately RMB 606.21 million after deducting issuance costs [1]. - The total amount of excess funds raised is RMB 210.30 million [4]. Investment Project Details - The total investment for the projects funded by the raised capital is RMB 395.92 million, with the funds allocated for these projects detailed in the prospectus [2][3]. Plan for Using Excess Funds - The company plans to use RMB 63 million, which is 29.96% of the total excess funds, to permanently supplement its working capital, ensuring that the needs of the fundraising investment projects are met [4]. - The use of excess funds is in compliance with regulations, as the cumulative amount used for this purpose in the last 12 months does not exceed 30% of the total excess funds [4]. Commitments and Explanations - The company commits that the cumulative use of excess funds for working capital will not exceed the total excess funds within any 12-month period and will not engage in high-risk investments or provide financial assistance to entities outside of its controlling subsidiaries within the next 12 months [4]. Approval Process - The proposal to use part of the excess funds was approved in the company's board and supervisory meetings held on June 11, 2025, and is pending approval from the shareholders' meeting [5]. Supervisory and Sponsor Opinions - The supervisory board supports the use of excess funds for working capital, stating it will not affect the normal implementation of fundraising projects and will not harm the interests of the company and its shareholders [5]. - The sponsor institution has no objections to the company's plan to use excess funds for working capital, confirming compliance with relevant laws and regulations [5].